# Growth Hormone in EB

> **NCT05390073** · — · UNKNOWN · sponsor: **Cairo University** · enrollment: 50 (estimated)

## Conditions studied

- Epidermolysis Bullosa Dystrophica

## Interventions

- **DIAGNOSTIC_TEST:** growth hormone level and insulin like growth factor 1

## Key facts

- **NCT ID:** NCT05390073
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-25
- **Primary completion:** 2022-06-10
- **Final completion:** 2022-06-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05390073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05390073, "Growth Hormone in EB". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05390073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*